Demo Sign up Log In

AstraZeneca PLC Ordinary Shares (AZN)

EBITDA

$5.16B

Quarterly · Period ending: Jun 30, 2026 · USD

AZN EBITDA

Latest reported$5.16Bperiod endingJun 30, 2026

Latest reported$5.16Bperiod endingJun 30, 2026

AZN Quarterly EBITDA ($1.75B → $5.16B)

Quarterly EBITDA

High-resolution chart · PNG

AZN ebitda history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

AstraZeneca PLC Ordinary Shares EBITDA — Quarterly (USD)
Period ending	EBITDA (USD)
Jun 30, 2001	1,152,686,992
Mar 31, 2001	1,302,764,294
Dec 31, 2000	1,290,612,066
Sep 30, 2000	1,187,053,533
Jun 30, 2000	1,239,855,256
Mar 31, 2000	1,193,460,144
Dec 31, 1999	-584,534,942
Sep 30, 1999	1,169,000,000
Jun 30, 1999	1,269,000,000
Mar 31, 1999	4,521,500,000
Dec 31, 1998	-5,417,783,334
Sep 30, 1998	2,330,200,000
Jun 30, 1998	869,000,000
Mar 31, 1998	2,417,500,000
Dec 31, 1997	-4,410,347,060
Sep 30, 1997	2,099,400,000
Jun 30, 1997	2,284,000,000
Mar 31, 1997	2,284,000,000
Dec 31, 1996	-2,847,807,606
Sep 30, 1996	2,313,600,000
Jun 30, 1996	2,278,500,000
Mar 31, 1996	2,278,500,000
Dec 31, 1995	-4,752,609,994
Sep 30, 1995	1,935,000,000
Jun 30, 1995	378,700,000
Mar 31, 1995	2,017,100,000
Dec 31, 1994	-4,029,861,579
Sep 30, 1994	1,752,800,000
Jun 30, 1994	1,836,800,000
Mar 31, 1994	1,836,800,000
Dec 31, 1993	-3,895,014,141
Sep 30, 1993	1,537,000,000
Jun 30, 1993	1,748,500,000
Mar 31, 1993	1,748,500,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.